Skip to main content

MoneyWorks4Me

ABL Bio Technologies informs about quarterly statement on investor complaints

19 Jul 2016 Evaluate

ABL Bio Technologies has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1888.50
Dr. Reddys Labs. 1380.85
Cipla 1403.50
Lupin 2015.00
Zydus Lifesciences 1200.00
View more..